Skip to main content

HIV-Associated TB - update 2020
Enrollment in this course is by invitation only

HIV-associated tuberculosis 2020 update
Enrollment in this course is by invitation only

About This Course

HIV-associated tuberculosis remains the major cause of death among HIV-infected individuals. New knowledge on how we can improve our efforts of effective prevention, early diagnosis and treatment of drug-susceptible TB and drug-resistant TB in HIV-infected individuals has been acquired. The most important latest developments and new recommendations being relevant for your daily practice will be discussed.

This 2 weeks course was prepared in collaboration with 3 reviewers from AHF: Dr. Adele Schwartz Benzaken, Senior Global Medical Director, Dr. Fernanda Moreira Rick, Associate Global Medical Director, and Dr. Jan van den Hombergh, Director Global Quality, and will be awarded with 3.0 AHF CME credit hours.

What you will learn

  • Epidemiology of HIV-associated TB
  • News on prevention of TB in PLHIV
  • Diagnosis of TB – update
  • News on treatment of drug-susceptible TB
  • News on treatment of drug-resistant TB
  • Course Staff Image #1

    Clemens Richter, MD PhD

    Frequently Asked Questions

    What web browser should I use?

    The eHealthAcademy platform works best with current versions of Chrome, Firefox or Safari, or with Internet Explorer version 9 and above.

    Enrollment in this course is by invitation only